Joshua Lyons
Surgery · Cleveland, OHNPI 1598159048
Payments from drug & device makers
Across 76 payments — averaging $347.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Endoscopy$17K
- Intuitive Surgical$2K
- Davol Inc.$2K
- BD$2K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$674
- plus $817 from 4 others
What the payments were for
- Consulting fees$17,00064%
- Travel & lodging$3,75914%
- Food & beverage$4,67718%
- Education$1,0004%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Endoscopy | 8 | $17,000 |
| Intuitive Surgical | 16 | $2,178 |
| Davol Inc. | 12 | $1,940 |
| BD | 16 | $1,924 |
| W. L. Gore & Associates, Inc. | 9 | $1,911 |
| Boston Scientific | 8 | $674 |
| Aroa Biosurgery Incorporated | 3 | $386 |
| Integra Lifesciences Corporation | 2 | $185 |
| TELA Bio, Inc. | 1 | $139 |
| Medtronic | 1 | $106 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Phasix Mesh$1,861
- GORE SYNECOR Biomaterial$1,326
- DAVINCI XI$1,000
- Da Vinci Surgical System$809
- GORE SYNECOR Preperitoneal Biomaterial$503
- INTEGRA$494
- SpyGlass Discover$381
- INTEGRA DERMAL REGENERATION TEMPLATE$165
- PRIMATRIX$165
- PROGEL$148
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$139
- SPYGLASS$113
- LigaSure$106
How this compares
$26,444 in reported general payments places this provider in the 90th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cleveland
- Raymond OndersCleveland$1.2M
- Clayton PetroCleveland$1.1M
- Ali AminianCleveland$1.1M
- Michael RosenCleveland$983K
- Neilendu KunduCleveland$808K
- Chase WehrleCleveland$741K
- Ihya GorgunCleveland$704K
- Craig JarrettCleveland$622K
- Bijan EghtesadCleveland$418K
- Leena KhaitanCleveland$406K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.